RB1 and central nervous system cancer: In order to analyze the immune response against transformed glioma cell lines with Rb deletion and/or RASV12 overexpression in an homologous syngeneic model of tumor transplantation, the percentages of different immune cell subpopulations were quantified in the peripheral blood of mice in which tumor cells had been injected 28 days earlier.